Paladin Advisory Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$190K Hold
1,478
0.13% 89
2026
Q1
$178K Hold
1,478
0.14% 90
2025
Q4
$156K Hold
1,478
0.11% 97
2025
Q3
$124K Sell
1,478
-390
-21% -$32.1K 0.1% 102
2025
Q2
$148K Hold
1,868
0.11% 98
2025
Q1
$168K Hold
1,868
0.13% 89
2024
Q4
$186K Sell
1,868
-249
-12% -$25.7K 0.14% 84
2024
Q3
$240K Hold
2,117
0.18% 77
2024
Q2
$271K Sell
2,117
-79
-4% -$10.2K 0.21% 74
2024
Q1
$288K Hold
2,196
0.23% 70
2023
Q4
$239K Sell
2,196
-9,492
-81% -$985K 0.2% 77
2023
Q3
$1.2M Buy
11,688
+63
+0.5% +$6.79K 1.01% 34
2023
Q2
$1.34M Buy
11,625
+61
+0.5% +$6.93K 1.08% 31
2023
Q1
$1.23M Buy
+11,564
New +$1.25M 1.02% 31
2022
Q2
Sell
-11,486
Closed -$1.02M 429
2022
Q1
$959K Buy
+11,486
New +$906K 0.78% 35

Other funds holding MRK

Paladin Advisory Group's MRK Position: Q2 2026 in Review

Paladin Advisory Group held its Merck (MRK) position steady in Q2 2026 at 1,478 shares worth $190K. The position accounts for 0.13% of the portfolio, ranked #89.

Paladin Advisory Group first reported a position in MRK in Q1 2022 and has held it in 15 quarters since. The position peaked at $1.34M in Q2 2023. 1,549 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Paladin Advisory Group held 1,478 shares of Merck worth $190K as of Q2 2026.
  • Paladin Advisory Group left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.13% of Paladin Advisory Group's portfolio in Q2 2026, its #89 holding.
  • Paladin Advisory Group first reported a position in Merck in Q1 2022 and has held it in 15 quarters since.
  • Paladin Advisory Group's Merck position peaked at $1.34M in Q2 2023.
  • 1,549 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Paladin Advisory Group's 13F filing for Q2 2026, filed 28 Jul 2026.